licensing deal to boost hiv drug access
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

Licensing deal to boost HIV drug access

Arab Today, arab today

Arab Today, arab today Licensing deal to boost HIV drug access

London - Afp

US pharmaceutical giant Gilead Sciences and an NGO called the Medicines Patent Pool announced a deal on Tuesday aimed at boosting access to HIV drugs in poorer countries through generic manufacturing. The HIV medicines tenofovir and emtricitabine, as well as two drugs that are still in clinical development, cobicistat and elvitegravir, will be made in low-cost copycat form under the licensing agreement. Included too is a combination of these drugs in a hoped-for single pill known as the Quad. The Medicines Patent Pool, founded by AIDS campaign group UNITAID in 2010, seeks to widen access to HIV drugs through voluntary licences with Big Pharma. The new deal is unusual because pharmaceutical companies very rarely allow licensing of drugs for public health while the product is still in clinical development. "Today marks a milestone in managing patents for public health. The licence agreement with Gilead Sciences will help make medicines available at a lower cost and in easier-to-use formulations without delays," said Ellen 't Hoen, executive director of the Medicines Patent Pool. "(...) People in developing countries often have to wait for years before they can access new health technologies. Today's agreement changed that." Gilead will pick up royalties of three to five percent of generic sales, but will waive royalties for any formulations of the drug that are used for children. Generic drugs have been essential in the effort to cast a lifeline to the millions of people in poor countries who are badly infected by the human immunodeficiency virus (HIV). Thanks to generics, the cost of the least expensive first-generation HIV treatment has dropped to less than $86 a patient annually from $10,000 in 2000. However, doctors need alternatives to these front-line drugs because some patients fail to respond to the treatment. In addition, the AIDS virus mutates, posing a long-term resistance problem. It is the first agreement between the Medicine Patents Pool and a pharmaceutical company. UNITAID, headed by former French foreign minister Philippe Douste-Blazy, was set up in September 2006 to boost funding to fight AIDS, tuberculosis and malaria. Its funding derives from a solidarity levy on airline tickets sold in 15 countries.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

licensing deal to boost hiv drug access licensing deal to boost hiv drug access

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

licensing deal to boost hiv drug access licensing deal to boost hiv drug access

 



GMT 09:37 2012 Saturday ,28 April

Asamoah Gyan celebrates UAE title

GMT 06:57 2017 Tuesday ,12 December

Latest Grateful Dead resurrection -- a duo

GMT 14:03 2017 Friday ,10 February

3 Chinese miners killed in accident in Albania

GMT 10:06 2018 Sunday ,14 January

Qanso, Kijian tackle recent developments

GMT 18:58 2017 Saturday ,04 March

Gold prices continue to fall

GMT 12:49 2017 Thursday ,24 August

Fadl Shaker could be arrested soon

GMT 02:06 2017 Monday ,30 October

May22/Jun21

GMT 22:28 2017 Thursday ,24 August

February20th-March20th

GMT 08:07 2017 Saturday ,18 November

BBA President visits BHA

GMT 02:27 2017 Saturday ,28 October

September24th-October23rd

GMT 14:20 2017 Saturday ,26 August

Former VW engineer gets 40 months
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday